Miltefosine/Paromomycin Phase III Trial for Treatment of Primary Visceral Leishmaniasis (VL) Patients in Eastern Africa
Clinical trial NCT03129646 · COMPLETED
Trial details
- NCT number
- NCT03129646
- Sponsor
- Drugs for Neglected Diseases
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-24
- Primary completion
- 2020-12-11
- Enrollment
- 439
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.